Soliqua Pen 100Units/mL 3mL with 3 (Insulin Glargine/Lixisenatide) Skip to content
Local deliveries in La Paz, Los Cabos, Querétaro, and San Miguel de Allende. National shipping to all of Mexico.
Local deliveries in La Paz, Los Cabos, Querétaro, and San Miguel de Allende. National shipping throughout Mexico

Soliqua Pen 100Units/mL 3mL with 3 (Insulin Glargine/Lixisenatide)

by Sanofi
Sold out
Original price $ 4,153.85
Original price $ 4,153.85 - Original price $ 4,153.85
Original price $ 4,153.85
Current price $ 3,738.46
$ 3,738.46 - $ 3,738.46
Current price $ 3,738.46

La venta de este medicamento requiere receta médica. Su dispensación está sujeta a la validación de la receta y al cumplimiento de la normativa sanitaria vigente. La información contenida en este sitio tiene fines exclusivamente informativos y comerciales, incluyendo la descripción y el precio del producto, y no sustituye la valoración, diagnóstico o prescripción de un profesional de la salud.

SKU 7501165011984
Availability:
Out of stock
Notify me when they have inventory available

¿Necesitas este producto u otro medicamento?

Este producto está agotado por el momento. Nuestros asesores farmacéuticos pueden ayudarte a conseguirlo o encontrar la mejor alternativa para tu tratamiento.

Contáctanos por WhatsApp

Category

Diabetes Medications

Line

Combined Insulin

Brand

Soliqua

Molecule

Insulin Glargine / Lixisenatide

Presentation

Pen 100Units/Ml 3Ml

Laboratory

Sanofi

Indications

Soliqua is indicated for the treatment of adults with type 2 diabetes mellitus who have not achieved adequate blood glucose control with metformin alone or in combination with other oral antidiabetic medications. This medication is used in patients who require insulin to help control their glucose levels, as well as in those who need a combination of insulin and a GLP-1 agonist to improve their glycemic control. Soliqua can be used in combination with other oral antidiabetics and/or insulin, as per medical evaluation.

Composition

Each milliliter of Soliqua contains 100 units of insulin glargine and 33 micrograms of lixisenatide. Other components include excipients that facilitate the formulation of the medication.

Contraindications

It is contraindicated in patients with known hypersensitivity to any of the components of Soliqua, as well as in those with diabetic ketoacidosis. It should not be used in patients who experience severe hypoglycemic episodes or who cannot identify the symptoms of hypoglycemia.

Precautions

Caution is recommended in patients with kidney or liver diseases, as the elimination of the components may be affected. Care should also be taken in patients with a history of pancreatitis, as well as in those with gastrointestinal disorders. It is important to monitor blood glucose levels regularly and adjust the dose as needed.

Storage

Store in refrigeration between 2°C and 8°C. Do not freeze. Once opened, the product can be stored at room temperature (up to 30°C) and must be used within 14 days. Keep out of reach of children.

Prescription required.

Consult your doctor.

Shipping

  1. Free home delivery by local branches on orders over $1000. Otherwise, a $50 fee will be added in the cities of Querétaro and La Paz, BCS, and $150 in San José del Cabo and Cabo San Lucas, BCS.
  2. FREE national shipping via ground on orders over $1,500.00. Otherwise, a fee of $170.00 MXN (One hundred seventy Mexican pesos) will be added for a standard package with dimensions up to 20cm x 20cm x 20cm and 1kg in weight, and $290.00 MXN (Two hundred ninety Mexican pesos) for packages exceeding the aforementioned dimensions or weight.
  3. In case of oversized items, the corresponding fee will apply according to the parcel service.
  4. Orders received after 2:00 PM will be shipped the next day.
  5. For more details, please consult our shipping policy.

Payment and Security

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Category

Diabetes Medications

Line

Combined Insulin

Brand

Soliqua

Molecule

Insulin Glargine / Lixisenatide

Presentation

Pen 100Units/Ml 3Ml

Laboratory

Sanofi

Indications

Soliqua is indicated for the treatment of adults with type 2 diabetes mellitus who have not achieved adequate blood glucose control with metformin alone or in combination with other oral antidiabetic medications. This medication is used in patients who require insulin to help control their glucose levels, as well as in those who need a combination of insulin and a GLP-1 agonist to improve their glycemic control. Soliqua can be used in combination with other oral antidiabetics and/or insulin, as per medical evaluation.

Composition

Each milliliter of Soliqua contains 100 units of insulin glargine and 33 micrograms of lixisenatide. Other components include excipients that facilitate the formulation of the medication.

Contraindications

It is contraindicated in patients with known hypersensitivity to any of the components of Soliqua, as well as in those with diabetic ketoacidosis. It should not be used in patients who experience severe hypoglycemic episodes or who cannot identify the symptoms of hypoglycemia.

Precautions

Caution is recommended in patients with kidney or liver diseases, as the elimination of the components may be affected. Care should also be taken in patients with a history of pancreatitis, as well as in those with gastrointestinal disorders. It is important to monitor blood glucose levels regularly and adjust the dose as needed.

Storage

Store in refrigeration between 2°C and 8°C. Do not freeze. Once opened, the product can be stored at room temperature (up to 30°C) and must be used within 14 days. Keep out of reach of children.

Prescription required.

Consult your doctor.